An assessment of serum leptin levels in patients with chronic viral hepatitis: A prospective study

BMC Gastroenterology

Volumn 7, Issue , 2007, Pages

  Manolakopoulos, Spilios ^a   Bethanis, Sotirios ^a   Liapi, Charis ^b   Stripeli, Fotini ^a   Sklavos, Pantelis ^a   Margeli, Alexandra ^b   Christidou, Aggeliki ^a   Katsanika, Aggeliki ^a   Vogiatzakis, Evangellos ^a   Tzourmakliotis, Dimitrios ^a   Theocharis, Stamatios ^b  

^a IASO GENERAL HOSPITAL   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B(E) ANTIGEN; INSULIN; LAMIVUDINE; LEPTIN; ALPHA2A INTERFERON; ANTIVIRUS AGENT; BIOLOGICAL MARKER; RIBAVIRIN;

ADOLESCENT; ADULT; AGED; ANEMIA; ARTICLE; BODY COMPOSITION; CHRONIC HEPATITIS; CLINICAL ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG RESPONSE; DRUG WITHDRAWAL; FATIGUE; FEMALE; GENOTYPE; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN TISSUE; IMMUNOASSAY; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIVER BIOPSY; LIVER FIBROSIS; MALE; MONOTHERAPY; PROGNOSIS; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; VIROLOGY; AGE; BLOOD; CASE CONTROL STUDY; COMPARATIVE STUDY; DOSE RESPONSE; DRUG ADMINISTRATION; DRUG COMBINATION; FOLLOW UP; HOSPITALIZATION; IMMUNOHISTOCHEMISTRY; LIVER FUNCTION TEST; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEEDLE BIOPSY; PATHOLOGY; PROBABILITY; REFERENCE VALUE; RISK FACTOR; SEX DIFFERENCE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGE FACTORS; AGED; ANTIVIRAL AGENTS; BIOLOGICAL MARKERS; BIOPSY, NEEDLE; CASE-CONTROL STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HEPATITIS B, CHRONIC; HEPATITIS C, CHRONIC; HUMANS; IMMUNOHISTOCHEMISTRY; INTERFERON ALFA-2A; LAMIVUDINE; LEPTIN; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROBABILITY; PROSPECTIVE STUDIES; REFERENCE VALUES; RIBAVIRIN; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SEX FACTORS; TREATMENT OUTCOME;

EID: 34347383552     PISSN: None     EISSN: 1471230X     Source Type: Journal    
DOI: 10.1186/1471-230X-7-17     Document Type: Article

References (39)

1. Zhang Y Proenca R Maffei M Barone M Leopold L Friedman JM Position cloning of the mouse obese gene and its human homologue Nature 1994 372 425-32 10.1038/372425a0 7984236
2. Spiegelman BM Flier JS Obesity and the regulation of energy balance Cell 2001 104 531-543 10.1016/S0092-8674(01)00240-9 11239410
3. Potter JJ Womack L Mezey E Anania FA Transdifferentiation of rat hepatic stellate cells results in leptin expression Biochem Biophys Res Commun 1998 244 178-182 10.1006/bbrc.1997.8193 9514867
4. Leclercq IA Farrell GC Schriemer R Robertson GR Leptin is essential for the hepatic fibrogenic response to chronic liver injury J Hepatol 2002 37 206-213 10.1016/S0168-8278(02)00102-2 12127425
5. Bethanis S Theocharis S Leptin in the field of hepatic fibrosis: A pivotal or incidental player? Dig Dis Sci 2006 51 1685-96 10.1007/ s10620-006-9126-0 16958000
6. Tsochatzis E Papatheodoridis GV Archimandritis AJ The evolving role of leptin and adiponectin in chronic liver diseases Am J Gastroenterol 2006 101 2629-40 16952281
7. Bolukbas FF Bolukbas C Horoz M Gumus M Erdogan M Zeyrek F Yayla A Ovunc O Child-Pugh classification dependent alterations in serum leptin levels among cirrhotic patients: A case controlled study BMC Gastroenterology 2004 4 23 522814 15387890 10.1186/1471-230X-4-23
8. Testa R Franceschini R Giannini E Cataldi A Botta F Fasoli A Tenerelli P Rolandi E Barreca T Serum leptin levels in patients with viral chronic hepatitis or liver cirrhosis J Hepatol 2000 33-33 37 10.1016/ S0168-8278(00)80156-7 10905583
9. Giannini E Botta F Cataldi A Tenconi GL Ceppa P Barreca T Testa R Leptin levels in nonalcoholic steatohepatitis and chronic hepatitis C Hepato-Gastroenterology 1999 46 2422-2425 10522010
10. Uygun A Kadayifci A Yesilova Z Erdil A Yaman H Saka M Deveci MS Bagei S Gulsen M Karaeren N Dagalp K Serum leptin levels in patients with nonalcoholic steatohepatitis Am J Gastroenterol 2000 95 3584-3588 10.1111/j.1572-0241.2000.03297.x 11151896
11. Ben-Ari Z Schaffer Z Sulkes J Manhaim V Tur-Kaspa R Fainaru M Alterations in serum leptin in chronic liver disease Dig Dis Sci 2002 47 183-189 10.1023/A:1013248427783 11837722
12. Comlekci A Akpinar H Yesil S Okan I Ellidokuz E Okan A Ersoz G Tankurt E Batur Y Serum leptin levels in patients with liver cirrhosis and chronic viral hepatitis Scand J Gastroenterol 2003 38 7 779-786 10.1080/ 00365520310003877 12889566
13. Greco AV Mingrone G Favuzzi A Capristo E Gnioli D Addolorato G Brunani A Cavagnin F Gasbarrini G Serum leptin levels in post-hepatitis cirrhosis J Hepatol 2000 33 33-37 10.1016/S0168-8278(00)80157-9 10905583
14. Ockenga J Bischoff SC Tilmann HL Rifai K Widjala A Boker KHW Manns MP Brabant G Elevated bound leptin correlates with energy expenditure in cirrhotics Gastroenterol 2000 119 6 1656-1662 10.1053/gast.2000.20256
15. Charlton MR Pockros PJ Harrison SA Impact of obesity on treatment of chronic hepatitis C Hepatology 2006 43 1177-1186 10.1002/hep.21239 16729327
16. Cohen B Novick D Rubinstein M Modulation of insulin activities by leptin Science 1996 274 1185-1188 10.1126/science.274.5290.1185 8895466
17. Matthews DR Hosker JP Rudenski AS Naylor BA Treacher DF Turner RC Homeostatic model assessment: Insulin resistance and beta-cell function from fasting glucose and insulin concentrations in man Diabetologia 1985 28 412-419 10.1007/BF00280883 3899825
18. Shintani Y Fujie H Miyoshi H Tsutsumi T Tsukamoto K Kimura S Moriya K Koike K Hepatitis C virus infection and diabetes: Direct involvement of the virus in the development of insulin resistance Gastroenterology 2004 126 840-848 10.1053/j.gastro.2003.11.056 14988838
19. Hadziyannis SJ Sette H Jr Morgan TR Balan V Diago M Marcellin P Ramadori G Bodenheimer H Jr Bernstein D Rizzetto M Zeuzem S Pockros PJ Lin A Ackrill AM PEGASYS International Study Group Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: A randomized study of treatment duration and ribavirin dose Ann Intern Med 2004 140 346-55 14996676
20. Ishak K Baptista A Bianchi L Callea F De Groote J Gudat F Denk H Desmet V Korb G MacSween RN Histological grading and staging of chronic hepatitis J Hepatol 1995 22 696-699 10.1016/0168-8278(95)80226-6 7560864
21. Brunt EM Nonalcoholic steatohepatitis: Definition and pathology Semin Liver Dis 2001 21 3-16 10.1055/s-2001-12925 11296695
22. Considine RV Sinha MK Heiman ML Kriauciunas A Stephens TW Nyce MR Ohannesian JP Marco CC McKee LJ Bauer TL Serum immunoreactive-leptin concentrations in normal weight and obese humans N Engl J Med 1996 334 292-5 10.1056/NEJM199602013340503 8532024
23. Crespo J Rivero M Fabrega E Cayon A Amado JA Garcia-Unzeta MT Pons-Romero F Plasma leptin and TNF-α levels in chronic hepatitis C patients and their relationship to hepatic fibrosis Dig Dis Sci 2002 47 1604-1610 10.1023/A:1015835606718 12141823
24. Zografos TA Rigopoulou EI Liaskos C Togousidis E Zachou K Gatselis N Germenis A Dalekos GN Alterations of leptin during IFN-α therapy in patients with chronic viral hepatitis J Hepatol 2006 44 848-855 10.1016/j.jhep.2006.01.025 16530290
25. Muzzi A Leandro G Rubbia-Brandt L James R Keiser O Malinverni R Dufour JF Helbling B Hadengue A Gonvers JJ Müllhaupt B Cerny A Mondelli MU Negro F Insulin resistance is associated with liver fibrosis in non-diabetic chronic hepatitis C patients J Hepatol 2005 42 41-46 10.1016/j.jhep.2004.09.022 15726693
26. Lin YS Wang YY Sheu WHH Increased serum leptin concentrations correlate with soluble tumour necrosis factor receptor levels in patients with cirrhosis Clin Endocrinol 2002 57 6 805-811 10.1046/ j.1365-2265.2002.01672.x
27. Henriksen JH Holst JJ Møller S Brinch K Bendtsen F Increased circulating leptin in alcoholic cirrhosis: Relation to release and disposal Hepatology 1999 29 1818-1824 10.1002/hep.510290601 10347125
28. Loffreda S Yang SQ Lin HZ Karp CL Brengman ML Wang DJ Klein AS Bulkley GB Bao C Noble PW Lane MD Diehl AM Leptin regulates proinflammatory responses FASEB J 1998 12 57-65 9438411
29. Bemeimans MH van Tits LJ Buurman WA Tumor necrosis factor: Function, release and clearance Crit Rev Immunol 1996 16 1-11 8809470
30. Manolakopoulos S Bethanis S Elefsiniotis J Karatapanis S Triantos C Sourvinos G Touloumi G Economou M Vlachogiannakos J Spandidos D Avgerinos A Tzourmakliotis D Lamivudine monotherapy in HBeAg-negative chronic hepatitis B: Prediction of response-breakthrough and long-term clinical outcome Aliment Pharmacol Ther 2006 23 787-95 10.1111/ j.1365-2036.2006.02806.x 16556181
31. Eguchi Y Mizuta T Yasutake T Hisatomi A Iwakiri R Ozaki I Fujimoto K High serum leptin is an independent risk factor for non-response patients with low-viremia to antiviral treatment in chronic hepatitis C World J Gastroenterol 2006 12 4 556-560 16489668
32. Chen M Bergman RN Pacini G Porte D Jr Pathogenesis of age-related glucose intolerance in man: Insulin resistance, and decreased β-cell function J Clin Endocrinol Metab 1985 60 13-20 3880560
33. Bonora E Coscelli C Orioli S Camb R Buzzell G Genlini P Butturini U Hyperinsulinemia of chronic active hepatitis: Impaired insulin removal rather than pancreatic hypersecretion Horm Metab Res 1984 16 111-4 6370817
34. Custro N Carrocio A Ganci A Scafidi V Campagna P Di Prima L Montalto G Glycemic homeostasis in chronic viral hepatitis and liver cirrhosis Diabetes Metab 2001 27 476-81 11547221
35. Hui JM Sud A Farrell GC Bandara P Byth K Kench JG McCaughan GW George J Insulin resistance is associated with chronic hepatitis C and virus infection fibrosis progression Gastroenterol 2003 125 6 1695-704 10.1053/ j.gastro.2003.08.032
36. Romero-Gomez M Insulin resistance and chronic hepatitis C World J Gastroenterol 2006 28 7075-7080
37. Fartoux L Poujol-Robert A Guechot J Wendum D Poupon R Serfaty L Insulin resistance is a cause of steatosis and fibrosis progression in chronic hepatitis C Gut 2005 54 1003-8 10.1136/gut.2004.050302 15951550
38. Romero-Gomez M Del Mar Viloria M Andrade RJ Salmeron J Diago M Fernandez-Rodriguez CM Corpas R Cruz M Grande L Vazquez L Munoz-De-Rueda P Lopez-Serrano P Gila A Gutierrez ML Perez C Ruiz-Extremera A Suarez E Castillo J Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients Gastroenterology 2005 128 636-41 10.1053/j.gastro.2004.12.049 15765399
39. D'Souza R Sabin CA Foster GR Insulin resistance plays a significant role in liver fibrosis in chronic hepatitis C and in the response to antiviral therapy Am J Gastroenterol 2005 100 1509-1515 10.1111/ j.1572-0241.2005.41403.x 15984973